CZResearcher profile · from public sources
Chuansheng Zheng
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Five-year Quantitative Chest CT and Hyperpolarized Xenon 129 Ventilation MRI Findings in Survivors of COVID-19 Pneumonia.
Radiology, Sept 2026
Publication
Impact of TACE combined with targeted and immune therapy on liver function and prognosis in unresectable hepatocellular carcinoma patients: the significance of baseline albumin-bilirubin grade.
Therapeutic advances in medical oncology, Jul 2026
Publication
Hepatic immune prognostic index as a prognostic biomarker in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Therapeutic advances in medical oncology, May 2026
Publication
Histogram analysis of diffusion kurtosis imaging for T restaging and predicting complete response of locally advanced rectal cancer following neoadjuvant immunotherapy.
Quantitative imaging in medicine and surgery, May 2026
Publication
Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.
Gut, Mar 2026
Publication
An Integrated QSM-Radiomics Nomogram With Clinical and Imaging Markers for Stratifying Cognitive Impairment in Hypertension.
CNS neuroscience & therapeutics, Feb 2026
Publication
Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial.
Nature medicine, Jan 2026
Publication
COX-2/PGE2 axis blockade with celecoxib enhances anti-PD-1 efficacy by activating natural killer cells for residual hepatocellular carcinoma after radiofrequency ablation.
Journal of experimental & clinical cancer research : CR, Dec 2025
Publication
Recent Advances in Embolic Agents for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Advanced healthcare materials, Nov 2025
Publication
Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACE.
BMC gastroenterology, Nov 2025
Publication
Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma.
European radiology, Nov 2025
Publication
The prognostic value of CT-measured body composition combined with radiomics in predicting the survival of patients with resectable colon cancer.
La Radiologia medica, Nov 2025
Publication
Non-invasive prediction of NSCLC immunotherapy efficacy and tumor microenvironment through unsupervised machine learning-driven CT radiomic subtypes: a multi-cohort study.
International journal of surgery (London, England), Jun 2025
Publication
Radiomics-Based Unsupervised Clustering Identifies Subtypes Associated With Prognosis and Immune Microenvironment in Clear Cell Renal Cell Carcinoma: A Multicenter Study.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), Jun 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error